What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (5 Viewers)

I feel it's a 60/40 for EUA/Approval. It would be 80/20 except my lack of confidence that FDA will be fair. I'm all in so it's up to the cards.

 
Last edited by a moderator:
Don’t understand why confidence has waned in here with literally no news. You guys are just coming up with your own imaginary numbers and attaching significance to them. 

 
My order at $4.20 (brah) did not quite hit. Hope you get back your principal and more soon.
Yeah.  I really didn't expect it to sink quite that low today.  I was ok getting back in at 4.70

If it stays low for a bit, or dips further, I will average down a little more.  I just have a starting position now, so it'd be easy to do.

 
Just sold all the shares acquired in the $4.27 to $4.50 range for a nice gain at $4.80.  Thank you shorts, see yah tomorrow.

 
Probably NP and MM with a little SK thrown in.
I've been out of the thread for a while. Did you ever spill the beans on the craziness behind the scenes you had alluded to before? Didn't know if I should go hunting back in the thread to see. I'm still holding some of my CYDY (admittedly not as much as most of you) so rooting for success still. 

 
Polish Hammer said:
I've been out of the thread for a while. Did you ever spill the beans on the craziness behind the scenes you had alluded to before? Didn't know if I should go hunting back in the thread to see. I'm still holding some of my CYDY (admittedly not as much as most of you) so rooting for success still. 
not yet

hoping to be able to do so at some point in the future

 
I don’t have time to watch the video right now but I don’t get it. 
He's claiming "insiders" (people who are aware good news is coming not company insiders) flooded the market with sell orders to take out stop limits.  Per his charting, the support level was $4.25 to $4.30 and these insiders began accumulating.  He claims it's a sure sign the stock will take off in the coming days.

 
I was thinking today how easy it would be to make a fortune by being on an advisory board that does the midterm peak for these trials.  You would probably get a 90% accuracy rate on determining if the drug will succeed or fail.  You just need a partner to play the stock for you.

 
He's claiming "insiders" (people who are aware good news is coming not company insiders) flooded the market with sell orders to take out stop limits.  Per his charting, the support level was $4.25 to $4.30 and these insiders began accumulating.  He claims it's a sure sign the stock will take off in the coming days.
the dip and rise back up happened in a pretty short period of time.   This was my thinking also that someone wanted to clear out those sell orders and buy as cheap as possible.   

It rose from the 2's to 6 pretty fast.  A couple of tests in the low 4's was to be expected imo before the next run up.

 
the dip and rise back up happened in a pretty short period of time.   This was my thinking also that someone wanted to clear out those sell orders and buy as cheap as possible.   

It rose from the 2's to 6 pretty fast.  A couple of tests in the low 4's was to be expected imo before the next run up.
Glad i was watching at that moment.  Banked $75 in no time.

 
Safe to say data was unblinded at the latest today or is there a possibility it could be later?
I'd say it's today but end of day and possibly a day or two earlier if they filled the trial prior to the P.R.  Hospitals still have to sign off on the data so that will take a little time before Amarex has it..

 
Last edited by a moderator:
Last edited by a moderator:
They will see some of the data tomorrow, but they probably won't see most of it until the weekend or next week.  The hospitals have to sign off on everything before sending it.

 
Safe to say data was unblinded at the latest today or is there a possibility it could be later?
We still don't know when the 28 day clock started.  The 390th patient was enrolled by Dec 15th.  We don't know when the 394th patient was enrolled.  Probably a day or two later.  There is also a delay between a patient being enrolled and them actually getting the shot.  The 28 day clock doesn't start until the last patient gets their first shot.  There is also a delay after the 28 day clock expires because hospitals need to turn in their data.  (IIRC, that took a few days with the M2M trial)  Only after all of the data is submitted to Amarex can unblinding happen.

 
Last edited by a moderator:
We still don't know when the 28 day clock started.  The 390th patient was enrolled by Dec 15th.  We don't know when the 394th patient was enrolled.  Probably a day or two later.  There is also a delay between a patient being enrolled and them actually getting the shot.  The 28 day clock doesn't start until the last patient gets their first shot.  There is also a delay after the 28 day clock expires because hospitals need to turn in their data.  (IIRC, that took a few days with the M2M trial)  Only after all of the data is submitted to Amarex can unblinding happen.
You are forgetting - CYDY's calendar is not 28 days or 30 days. Always add 14 more days to that calendar..

 
I seem to remember that unblinding was announced with the M2M trial.  Does anyone remember it being announced and how it was announced?  Maybe Patterson or Dr Yo announced it on Twitter?

 
Read these two. Sounds like a knowledgeable person

IH Link1

Link2
The first link is great.  The second not so much.  Where he says, "Now we know there are 87 deaths and we know there will be more. It is sad to say this but the more no of deaths, the better chance to have a positive outcome." That statement is 100% false.  50 or 60 total deaths would have guaranteed great data for leronlimab.  With 87-90 deaths, it is a very narrow path to statistical significance.

 
Yea, @Don Hutson It will be interesting to post analyze this to see if that's correct. Could be that SOC mortality is higher for our trial but I agree with your point. Chet seems to agree on the first link as well 😆

 
Could be that SOC mortality is higher for our trial but I agree with your point.
I think I remember the trial being two-thirds severe from the interim analysis.  But I might be wrong.  I might have just been using Otto Yang's severe/critical ratio which is two-thirds severe.  It would help leronlimab's chances immensely if critical patients are half or two-thirds of the trial since they die at 2 or 3 times the rate of severe patients.

 
Last edited by a moderator:
Literally no idea what that means 
He has something to sell you after leronlimab gets approval.  I think he wants to do a longhauler test that uses a tiny amount of leronlimab.  Maybe CytoDyn will be giving the leronlimab to Bruce for free in exchange for a tweet implying that leronlimab will get approval.

 
Last edited by a moderator:

Users who are viewing this thread

Back
Top